Systemic
injections of
MK-801, a selective NMDAR antagonist, into neonatal rats induces long-term neurochemical and behavioural changes. It has been suggested that these changes form the neurodevelopmental basis for
schizophrenia-like behaviour in rats. In this study, 7-d-old rats were treated with
MK-801, and their frontal cortices were examined to investigate the effects on p70S6K-S6 signal pathway and on protein translation, which play crucial roles in the neurodevelopmental process.
MK-801, in doses of 0.5 and 1.0 mg/kg, induced a decrease in phosphorylation of
p70S6K and its substrates, S6 and
eIF4B, in the first 8 h, and no change at 24 and 48 h. These effects were more prominent after two
injections of
MK-801 than one. Decreased S6 phosphorylation by
MK-801 was evident in the prefrontal, cingulate, and insular cortex. In two representative upstream p70S6K-S6 pathways related to ERK1/2 and Akt, changes in ERK1/2-p90RSK phosphorylation were accompanied by changes of p70S6K-S6. Although two
MK-801 injections induced a dose-dependent decrease in phosphorylation of Akt and mTOR at 4 and 8 h, a single injection did not produce a significant effect.
Protein synthesis rate, measured by [3H]
leucine incorporation in frontal cortical tissue, was reduced until 24 h after two
MK-801 (1.0 mg/kg)
injections. In summary, this study found that neonatal
MK-801 treatment induced dysregulation in the
p70S6K-S6/
eIF4B pathway and protein translation in the frontal cortex of the developing rat brain, which may suggest an important role of protein translation machinery in the
MK-801 neurodevelopmental animal model of
schizophrenia.